Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Facioscapulohumeral Muscular Dystrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06517498
What this trial is testing

Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Xi'an Jiaotong University 300
Not applicableStudy completedNCT01596803
What this trial is testing

Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University Hospital, Montpellier 54
Large-scale testing (Phase 3)Ended earlyNCT05397470
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 260
Early research (Phase 1)Study completedNCT03123913
What this trial is testing

Study of Testosterone and rHGH in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Rochester 20
Not applicableStudy completedNCT04267354
What this trial is testing

Arm Cycling in Facioscapulohumeral Dystrophy (FSHD) Patients

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust 15
Not applicableStudy completedNCT04377217
What this trial is testing

Computerized Facial Recognition for Automated Diagnosis of the Facio-Scapulo-Humeral Muscular Dystrophy (FSMHD)

Who this might be right for
Facio-Scapulo-Humeral Dystrophy
Centre Hospitalier Universitaire de Nice 17
Early research (Phase 1)UnknownNCT02208713
What this trial is testing

Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD)

Who this might be right for
Dystrophy
Royan Institute 21
Not applicableLooking for participantsNCT06079567
What this trial is testing

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice 50
Not applicableLooking for participantsNCT06227182
What this trial is testing

Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Radboud University Medical Center 100
Not applicableStudy completedNCT02948244
What this trial is testing

Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD

Who this might be right for
Facio-Scapulo-Humeral DystrophyFSHD2FSHD1
Murdoch Childrens Research Institute 11
Testing effectiveness (Phase 2)Ended earlyNCT04004000
What this trial is testing

Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Fulcrum Therapeutics 14
Not applicableLooking for participantsNCT04001582
What this trial is testing

The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Newcastle University 1,018
Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Not applicableActive Not RecruitingNCT01671865
What this trial is testing

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 75
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Testing effectiveness (Phase 2)Study completedNCT02531217
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 9
Not applicableStudy completedNCT02032979
What this trial is testing

Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice 6
Not applicableUnknownNCT02541292
What this trial is testing

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1a
Rigshospitalet, Denmark 10
Not applicableStudy completedNCT07331025
What this trial is testing

Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings

Who this might be right for
Facioscapulohumeral Muscular DystrophyFacioscapulohumeral Muscular Dystrophy 1Neuromuscular Disease
Koç University 39
Testing effectiveness (Phase 2)Study completedNCT02603562
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 8
Next Page